Skip to main content
Caplight Logo









MB Therapeutics

MB Therapeutics

Private
MontpellierHealthcare & Life Scienceshttps://mb-therapeutics.com/en/home/

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MB Therapeutics is a biotechnology company developing a solution for manufacturing personalized medicine through 3D printing for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

pharmaceutical 3D printing3D printed medicinepersonalized medicineon-demand drug manufacturing3D printed pillsprecision medicinepoint-of-care manufacturingautomated compoundingpharmacy automationpharmaceutical 3D printerdecentralized drug manufacturingpersonalized dosageGMP manufacturingdrug shortage solutionpediatric drug deliverypharmaceutical cartridges

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MB Therapeutics Comparables

Compare MB Therapeutics with similar companies based on industry and business-model similarity.

MB Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Doser
88%
FabRx
88%
CurifyLabs
87%

MB Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Stéphane Roulon

CEO & Co-founder - Production Of Personalized Medications Through 3D Printing

Founding Team

Ian Soulairol

Chief Technology Officer

Executive Team

Damien STEFANELLI

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 57% MoM.

  • Jul 20, 2026

    Open roles increased to 3, 2.4x the trailing average.

MB Therapeutics Filings

Explore SEC and related filing metadata, where available.

MB Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MB Therapeutics's valuation, stock price, and market status.

Is MB Therapeutics a public or private company?

MB Therapeutics is a private company.

What is the current stock price of MB Therapeutics?

MB Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is MB Therapeutics worth (valuation)?

Valuation information for MB Therapeutics is not publicly available.

Can I buy MB Therapeutics stock?

MB Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MB Therapeutics's last funding round?

Funding round information for MB Therapeutics is not publicly available.

Who are the main investors in MB Therapeutics?

Investor information for MB Therapeutics is not publicly disclosed.

Will MB Therapeutics IPO soon?

No public IPO plans have been announced for MB Therapeutics.

How can I track MB Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MB Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontpellier
Employee Range13
Year Founded2023
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?